1. Home
  2. NVAX vs AFYA Comparison

NVAX vs AFYA Comparison

Compare NVAX & AFYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.30

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Afya Limited

AFYA

Afya Limited

HOLD

Current Price

$14.87

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVAX
AFYA
Founded
1987
1999
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
NVAX
AFYA
Price
$8.30
$14.87
Analyst Decision
Hold
Hold
Analyst Count
9
4
Target Price
$10.78
$17.25
AVG Volume (30 Days)
6.4M
136.2K
Earning Date
02-26-2026
03-12-2026
Dividend Yield
N/A
1.52%
EPS Growth
N/A
25.39
EPS
2.07
1.50
Revenue
$1,064,651,000.00
$681,742,784.00
Revenue This Year
$58.91
$14.73
Revenue Next Year
N/A
$7.73
P/E Ratio
$4.20
$10.21
Revenue Growth
20.27
14.07
52 Week Low
$5.01
$13.12
52 Week High
$10.65
$19.90

Technical Indicators

Market Signals
Indicator
NVAX
AFYA
Relative Strength Index (RSI) 49.48 51.75
Support Level $9.16 $13.34
Resistance Level $10.20 $15.46
Average True Range (ATR) 0.69 0.48
MACD -0.09 0.07
Stochastic Oscillator 22.67 74.79

Price Performance

Historical Comparison
NVAX
AFYA

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

Share on Social Networks: